Ouki is a research acceleration platform that uses AI to analyze medical literature and identify novel connections between FDA-approved drugs and disease treatments.
AI analyzes recent medical research across multiple disease conditions
Identifies novel connections between FDA-approved drugs and treatment opportunities
Multi-factor scoring system assesses novelty, plausibility, and actionability
High-scoring hypotheses published for researcher review and validation
Hydroxychloroquine + Suvorexant
Targets cGAS-STING-glymphatic-gut axis to break self-amplifying neurodegeneration cycle
April 13, 2026Statins (via 27-hydroxycholesterol)
Novel connection between cholesterol metabolism and rhinovirus treatment
April 10, 2026LIFU Neuromodulation
Non-invasive ultrasound therapy promotes remyelination in MS lesions
April 13, 2026Ouki generates research hypotheses, not medical advice. All findings require validation by qualified medical researchers through proper clinical studies. This platform is designed as a research acceleration tool for the scientific community.